---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-026002"
form_type: "8-K"
ticker: "BCPC"
cik: "0000009326"
company_name: "BALCHEM CORP"
filed_at: "2023-07-28T23:59:59+00:00"
generated_at: "2026-06-12T23:30:19.018875+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Balchem Q2 sales $231.3M (-2.3% YoY); adjusted EPS $1.06; record EBITDA

## Summary
- Q2 net sales $231.3M, down 2.3% YoY; GAAP net earnings $30.1M ($0.93 EPS).
- Record quarterly adjusted EBITDA $59.1M, up 4.6% YoY; adjusted EPS $1.06 (vs $1.07 prior year).
- Operating cash flow $35.0M; free cash flow $31.7M; repaid $26M revolving debt, net debt $338.7M.
- Leverage ratio 1.5x net debt; completed new Vitacholine manufacturing unit for choline production.
- Effective tax rate declined to 21.6% from 24.1% (255 bps lower).

## SEC filing metadata
- accession: 0001628280-23-026002
- form_type: 8-K
- ticker: BCPC
- cik: 0000009326
- company_name: BALCHEM CORP
- filed_at: 2023-07-28T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/9326/000162828023026002/0001628280-23-026002-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/9326/000162828023026002/bcpc-20230728.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-026002
- JSON: https://secwatch.observer/filing/0001628280-23-026002.json
- Plain text: https://secwatch.observer/filing/0001628280-23-026002.txt

## Key facts
- Earnings Releases
  BALCHEM CORP reported the quarter ended June 30, 2023 results: revenue $231.3 million, net income $30.1 million, EPS $0.93.
  - Period: the quarter ended June 30, 2023
  - Revenue: $231.3 million
  - Net income: $30.1 million
  - EPS: $0.93
  - Result: reported results
  source text: • Second quarter net sales were $231.3 million, a decrease of $5.4 million, or 2.3%, compared to the prior year. • Record quarterly adjusted EBITDA was $59.1 million, an increase of $2.6 million, or 4.6%, from the prior year. • GAAP net earnings were $30.1 million, an increase of $0.3 million, or 1.1% from the prior year. These net earnings resulted in GAAP earnings per share of $0.93.
  evidence_url: https://www.sec.gov/Archives/edgar/data/9326/000162828023026002/0001628280-23-026002-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.